Characterization and Gene Expression Analysis of Serum-Derived Extracellular Vesicles in Primary Aldosteronism
- PMID: 31230554
- DOI: 10.1161/HYPERTENSIONAHA.119.12944
Characterization and Gene Expression Analysis of Serum-Derived Extracellular Vesicles in Primary Aldosteronism
Abstract
Patients affected by primary aldosteronism (PA) display an increased risk of cardiovascular events compared with essential hypertension (EH). Endothelial dysfunction favors initiation and progression of atherosclerosis and circulating extracellular vesicles (EVs), reflecting endothelial cell activity, could represent one of the mediators of endothelial dysfunction in these patients. The aim of this study was to characterize circulating EVs from patients diagnosed with PA and to explore their functional significance. Serum EVs were isolated from 12 patients with PA and 12 with EH, matched by sex, age, and blood pressure, and compared with 8 normotensive controls. At nanoparticle tracking analysis, EVs concentration was 2.2× higher in patients with PA ( P=0.033) compared with EH and a significant correlation between EV number and serum aldosterone and potassium levels was identified. Fluorescence-activated cell sorting analysis demonstrated that patients with PA presented a higher absolute number of endothelial-derived EVs compared with both patients with EH and normotensive controls. Through EV mRNA profiling, 15 up-regulated and 4 down-regulated genes in patients with PA compared with EH were identified; moreover, EDN1 was expressed only in patients with PA. Microarray platform was validated by quantative real-time polymerase chain reaction on 4 genes ( CASP1, EDN1, F2R, and HMOX1) involved in apoptosis, inflammation, and endothelial dysfunction. After unilateral adrenalectomy, EVs number and expression of CASP1 and EDN1 significantly decreased in patients with PA ( P<0.05). Additionally, the incubation with PA-derived EVs reduced angiogenesis and induced apoptosis in vitro. Circulating EVs might not only represent a marker of endothelial dysfunction but also contribute themselves to vascular dysfunction in patients with PA.
Keywords: aldosterone; endothelin-1; endothelium; extracellular vesicles; hypertension.
Comment in
-
Extracellular Vesicles as Biomarkers and Biovectors in Primary Aldosteronism.Hypertension. 2019 Aug;74(2):250-252. doi: 10.1161/HYPERTENSIONAHA.119.13088. Epub 2019 Jun 24. Hypertension. 2019. PMID: 31230536 No abstract available.
Similar articles
-
Serum Alpha-1-Acid Glycoprotein-1 and Urinary Extracellular Vesicle miR-21-5p as Potential Biomarkers of Primary Aldosteronism.Front Immunol. 2021 Nov 5;12:768734. doi: 10.3389/fimmu.2021.768734. eCollection 2021. Front Immunol. 2021. PMID: 34804057 Free PMC article.
-
Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis.J Clin Endocrinol Metab. 2011 Oct;96(10):3175-83. doi: 10.1210/jc.2011-1135. Epub 2011 Aug 3. J Clin Endocrinol Metab. 2011. PMID: 21816781
-
Comparison of biomarkers of endothelial dysfunction and microvascular endothelial function in patients with primary aldosteronism and essential hypertension.J Renin Angiotensin Aldosterone Syst. 2021 Jan-Dec;22(1):1470320321999491. doi: 10.1177/1470320321999491. J Renin Angiotensin Aldosterone Syst. 2021. PMID: 33678006 Free PMC article.
-
Primary Aldosteronism, Aldosterone, and Extracellular Vesicles.Endocrinology. 2022 Jan 1;163(1):bqab240. doi: 10.1210/endocr/bqab240. Endocrinology. 2022. PMID: 34918071 Review.
-
Extracellular Vesicles as Messengers in Atherosclerosis.J Cardiovasc Transl Res. 2020 Apr;13(2):121-130. doi: 10.1007/s12265-019-09923-z. Epub 2019 Oct 29. J Cardiovasc Transl Res. 2020. PMID: 31664614 Review.
Cited by
-
Progress on Genetic Basis of Primary Aldosteronism.Biomedicines. 2021 Nov 17;9(11):1708. doi: 10.3390/biomedicines9111708. Biomedicines. 2021. PMID: 34829937 Free PMC article. Review.
-
Extracellular Vesicles and Their Emerging Roles as Cellular Messengers in Endocrinology: An Endocrine Society Scientific Statement.Endocr Rev. 2022 May 12;43(3):441-468. doi: 10.1210/endrev/bnac009. Endocr Rev. 2022. PMID: 35552682 Free PMC article.
-
Role of Extracellular Vesicles in the Pathogenesis of Vascular Damage.Hypertension. 2022 May;79(5):863-873. doi: 10.1161/HYPERTENSIONAHA.121.17957. Epub 2022 Feb 11. Hypertension. 2022. PMID: 35144490 Free PMC article. Review.
-
Interplay between caveolin-1 and mineralocorticoid receptor in cardiometabolic disease.J Endocrinol. 2024 Jul 18;262(3):e230341. doi: 10.1530/JOE-23-0341. Print 2024 Sep 1. J Endocrinol. 2024. PMID: 38916410 Free PMC article. Review.
-
Knockout of the circadian clock protein PER1 results in sex-dependent alterations of ET-1 production in mice in response to a high-salt diet plus mineralocorticoid treatment.Can J Physiol Pharmacol. 2020 Sep;98(9):579-586. doi: 10.1139/cjpp-2019-0688. Epub 2020 Sep 11. Can J Physiol Pharmacol. 2020. PMID: 32437627 Free PMC article.